Walker Innovation (WLKR) 10-Q 14 Nov 13 2013 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Nov. 13, 2013
Document Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-13	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'
Trading Symbol	'GLOI	'
Entity Registrant Name	'PATENT PROPERTIES, INC.	'
Entity Central Index Key	'0001294649	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	20,741,572

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Current Assets:	'	'
Cash	$26,580	'
Accounts receivable, net	19	3,663
Prepaid and other current assets	460	164
Total current assets	27,059	3,827
Other Assets:	'	'
Investments, at cost	250	250
TOTAL ASSETS	27,309	4,077
Current Liabilities:	'	'
Accounts payable	176	465
Accrued expenses	1,284	1,684
TOTAL LIABILITIES	1,460	2,149
COMMITMENTS AND CONTINGENCIES	'	'
STOCKHOLDERS' EQUITY	'	'
Preferred stock, $0.001 par value, 15,000,000 shares authorized Series B Convertible Preferred stock, $0.001 par value, 14,999,000 shares designated, issued and outstanding	15	15
Common stock, $0.001 par value, 100,000,000 shares authorized; 21,134,744 and 7,667,667 shares issued as of September 30, 2013 and December 31, 2012, respectively	21	8
Treasury stock, at cost	-840	'
Additional paid-in capital	33,402	-23
Accumulated deficit	-6,749	1,928
TOTAL STOCKHOLDERS' EQUITY	25,849	1,928
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$27,309	$4,077

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Sep. 30, 2013	Sep. 18, 2013	Dec. 31, 2012
Preferred stock, par value	$0.00	'	$0.00
Preferred stock, authorized	15,000,000	'	15,000,000
Common stock, par value	$0.00	$0.00	$0.00
Common stock, authorized	100,000,000	'	100,000,000
Common stock, shares issued	21,134,744	7,667,667	7,667,667
Series B Convertible Preferred Stock	'	'	'
Preferred stock, shares issued	14,999,000	'	14,999,000
Preferred stock, shares outstanding	14,999,000	'	14,999,000

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenues:	'	'	'	'
Licensing fees	$956	$6,187	$2,080	$15,657
Patent sales	'	'	'	1,600
Total revenues	956	6,187	2,080	17,257
Cost of revenues:	'	'	'	'
Legal and consulting contingency fees	416	2,899	803	6,762
Other legal and consulting fees	326	753	1,269	1,973
Electronic data set-up fees	'	'	'	1,600
Total cost of revenue	742	3,652	2,072	10,335
Net revenue	214	2,535	8	6,922
Operating expenses:	'	'	'	'
Compensation and benefits	1,456	1,296	2,052	2,659
Professional fees	5,582	'	5,874	'
Patent expenses	213	162	620	620
General and administrative	69	44	139	130
Total operating expenses	7,320	1,502	8,685	3,409
Net income (loss)	-7,106	1,033	-8,677	3,513
Net income (loss) per common share:	'	'	'	'
Basic	($0.76)	$0.13	($1.06)	$0.46
Diluted	($0.76)	$0.05	($1.06)	$0.15
Weighted average common shares outstanding:	'	'	'	'
Basic	9,310,882	7,667,667	8,221,424	7,667,667
Diluted	9,310,882	22,666,667	8,221,424	22,666,667
PRO FORMA COMPUTATION RELATED TO CONVERSION TO C CORPORATION FOR INCOME TAX PURPOSES (unaudited):	'	'	'	'
Net income (loss)	-7,106	1,033	-8,677	3,513
Pro forma weighted average basic shares outstanding	9,310,882	7,667,667	8,221,424	7,667,667
Pro forma weighted average diluted shares outstanding	9,310,882	22,666,667	8,221,424	22,666,667
Pro forma basic earnings (loss) per share	($0.46)	$0.08	($0.63)	$0.27
Pro forma diluted earnings (loss) per share	($0.46)	$0.03	($0.63)	$0.09
Pro forma	'	'	'	'
Operating expenses:	'	'	'	'
Net income (loss)	-4,264	620	-5,206	2,108
PRO FORMA COMPUTATION RELATED TO CONVERSION TO C CORPORATION FOR INCOME TAX PURPOSES (unaudited):	'	'	'	'
Benefit (provision) for income taxes	2,842	-413	3,471	-1,405
Net income (loss)	($4,264)	$620	($5,206)	$2,108

CONSOLIDATED_STATEMENTS_OF_STO

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)

Total

Financial Advisory [Member]

Employee Stock

Preferred Stock

Common Stock

Common Stock

Common Stock

Treasury Stock [Member]

Additional Paid-in Capital

Additional Paid-in Capital

Additional Paid-in Capital

Retained Earnings

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Financial Advisory [Member]

Employee Stock

USD ($)

USD ($)

Financial Advisory [Member]

Employee Stock

USD ($)

USD ($)

USD ($)

USD ($)

Stockholders Equity beginning balance at Dec. 31, 2012

$1,928,000

'

'

$15,000

$8,000

'

'

'

($23,000)

'

'

$1,928,000

Stockholders Equity beginning balance, shares at Dec. 31, 2012

'

'

'

14,999,000

7,667,667

'

'

'

'

'

'

'

Net assets received and shares outstanding at time of reverse merger completed on September 18, 2013

15,216,000

'

'

'

7,000

'

'

-713,000

15,922,000

'

'

'

Net assets received and shares outstanding at time of reverse merger completed on September 18, 2013 (in shares)

'

'

'

'

6,552,352

'

'

354,592

'

'

'

'

Net assets received and shares outstanding at time of reverse merger completed on September 18, 2013, shares

'

'

'

'

6,552,352

'

'

354,592

'

'

'

'

Net contribution to related party shareholder

290,000

'

'

'

'

'

'

'

290,000

'

'

'

Incentive shares vested, value

'

4,441,000

614,000

'

'

1,000

'

'

'

4,440,000

614,000

'

Incentive shares vested, shares

'

'

'

'

'

1,325,776

183,334

'

'

'

'

'

Incentive shares granted- Vendor

343,000

'

'

'

1,000

'

'

'

342,000

'

'

'

Incentive shares granted- Vendor, Shares

1,445,000

'

'

'

1,445,000

'

'

'

'

'

'

'

Repurchase of treasury shares at cost

'

'

'

'

'

'

'

-127,000

127,000

'

'

'

Repurchase of treasury shares at cost, shares

'

'

'

'

'

'

'

38,580

'

'

'

'

Issuance of 3,960,615 shares common stock and 1,980,318 warrants, net of cost of $0.2 million

11,694,000

'

'

'

4,000

'

'

'

11,690,000

'

'

'

Issuance of 3,960,615 shares common stock and 1,980,318 warrants, net of cost of $0.2 million, shares

'

'

'

'

3,960,615

'

'

'

'

'

'

'

Net loss

-8,677,000

'

'

'

'

'

'

'

'

'

'

-8,677,000

Stockholders Equity ending balance, shares at Sep. 30, 2013

$25,849,000

'

'

$14,999,000

$21,134,744

'

'

$393,172

'

'

'

'

Stockholders Equity ending balance at Sep. 30, 2013

25,849,000

'

'

15,000

21,000

'

'

-840,000

33,402,000

'

'

-6,749,000

CONSOLIDATED_STATEMENTS_OF_STO1

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) (USD $)	9 Months Ended
In Millions, except Share data, unless otherwise specified	Sep. 30, 2013
Issuance of shares common stock and warrants, warrant to purchase common stock	1,980,318
Issuance of shares common stock and warrants, issuance cost	$0.20

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Cash Flows From Operating Activities:	'	'
Net income (loss)	($8,677)	$3,513
Adjustments to reconcile net income (loss) to net cash used in operating activities:	'	'
Net contribution (distribution) to related party shareholder	290	-4,701
Stock based compensation	5,398	'
Decrease (increase) in:	'	'
Accounts receivable, net	3,657	655
Prepaid and other current assets	-208	42
Increase (decrease) in:	'	'
Accounts payable	-289	-217
Accrued expenses	-679	708
Net cash provided by (used in) operating activities	-508	'
Cash Flows From Investing Activities:	15,394	'
Cash received in reverse merger transaction	15,394	'
Cash Flows From Financing Activities:	11,694	'
Issuance of common stock and warrants, net of cost	11,694	'
Net change in cash	26,580	'
Cash:	'	'
Ending	26,580	'
Purchase of assets and liabilities in connection with reverse merger:	'	'
Accounts receivable, net	13	'
Prepaid and other current assets	88	'
Accrued expenses	($279)	'

ORGANIZATION_AND_NATURE_OF_BUS

ORGANIZATION AND NATURE OF BUSINESS	9 Months Ended
	Sep. 30, 2013
ORGANIZATION AND NATURE OF BUSINESS	'
	NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS
	Organization
	Patent Properties, Inc. and Subsidiaries (the “Company”) was previously known as GlobalOptions Group, Inc. (a Delaware corporation) with a wholly owned subsidiary GlobalOptions, Inc. On July 11, 2013, the Company entered into an Agreement and Plan of Merger with GO Merger Sub LLC, a wholly-owned subsidiary of the Company (“Merger Sub”), Walker Digital, LLC (“Walker Digital”) and Walker Digital Holdings, LLC, a wholly-owned subsidiary of Walker Digital (“Walker Digital Sub”) pursuant to which, on September 18, 2013 (the “Closing Date”), Merger Sub merged with and into Walker Digital Sub (the “Merger”), with Walker Digital Sub surviving the Merger and becoming a wholly-owned subsidiary of the Company (the “Merger Agreement Subsequent to the Closing Date, the Company changed its name from GlobalOptions Group, Inc.to Patent Properties, Inc. and Walker Digital Sub changed its name to Inventor Holdings, LLC (“IH LLC”).
	The Merger was a reverse merger that was accounted for as a recapitalization of IH LLC as IH LLC is the accounting acquirer. Accordingly, the historical financial statements presented are the financial statements of IH LLC.
	Walker Digital Licensing and Enforcement (“WDLE”), a business segment of Walker Digital, develops and commercializes patents and other intellectual property assets created by Walker Digital, the research and development lab founded and led by Jay Walker. Immediately prior to the merger, as more fully disclosed below, Walker Digital transferred the intellectual property assets created by Walker Digital to the newly-formed entity named IH LLC.
	Pursuant to the terms and conditions of the Merger Agreement, on the Closing Date, Merger Sub was merged with and into IH LLC in accordance with the Delaware Limited Liability Company Act. All of the issued and outstanding membership interests in IH LLC were converted into 14,999,000 shares of the Company’s newly-designated Series B Convertible Preferred Stock, par value $0.001 per share, and 7,667,667 shares of our common stock, par value $0.001 per share (collectively, the “Merger Consideration”). As a result of the Merger, Walker Digital acquired 37% percent of our issued and outstanding common stock and 100% of the Company’s issued and outstanding Series B Convertible Preferred Stock (and, assuming conversion of all such shares of Series B Convertible Preferred Stock, 64%, of our issued and outstanding common stock) and IH LLC became our wholly-owned subsidiary. As a result of the Merger, Walker Digital has 87.4% controlling voting interest. The Company is now a holding company with primary operations conducted through IH LLC, although we anticipate that IH LLC will transfer a patent licensing system to us or another of our subsidiaries. Shares received by Walker Digital are subject to lock-up agreements whereby such shares cannot be sold or transferred for a period of one year following the Closing Date, other than to affiliates and to current and former officers or members of Walker Digital and its affiliates (and on the condition such transferees enter into a similar lock-up agreement), upon a pledge of such securities (and on condition such pledgee will enter into a similar lock-up agreement) or in a secondary sale contemplated in connection with the merger. Walker Digital may also receive an additional 2,166,667 shares subject to certain performance conditions.
	Substantially with the closing of the Merger, the Company completed the closing of a private placement (the “Placement”) of units, each consisting of one newly issued share of common stock and one warrant to purchase half a share of newly issued common stock, at the price of $3.00 per unit, to unaffiliated, accredited third parties. The investors in the Placement collectively purchased 3,960,615 shares of common stock and warrants to purchase 1,980,318 shares of common stock for consideration, net of offering costs of $0.2 million, of $11.7 million. The warrants (the “Warrants”) issued to the investors are exercisable for a period of three years at a purchase price of $3.00 per share of common stock and are subject to a call that permits the Company to redeem the Warrants if the closing price of the common stock of the Company equals or exceeds $6.00 per share for any 20 trading days within any period of 30 consecutive trading days.
	Nature of Business
	The Company develops, licenses and otherwise enforces patented technologies. The Company generates revenues from the granting of intellectual property rights for the use of, or pertaining to, patented technologies. The Company also monetizes its intellectual property to include the sale of select patent assets. Patent protection is a key part of the Company’s business model, because it provides the Company with a period of exclusive ownership during which the Company can recoup risk capital and generate a profit from inventions. As an entrepreneurially driven entity, the Company is committed to a flexible approach when it comes to business models, deal terms and allocations of risk.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Basis of Presentation
	The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information, the instructions to Form 10-Q and the rules and regulations of the SEC. Accordingly, since they are interim statements, the accompanying condensed consolidated financial statements do not include all of the information and notes required by GAAP for annual financial statements, but reflect all adjustments consisting of normal, recurring adjustments, that are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. In the opinion of the Company’s management, all adjustments, consisting of only normal and recurring adjustments, necessary for a fair presentation of the financial position and the results of operations for the periods presented have been included. Interim results are not necessarily indicative of results for a full year. The condensed consolidated financial statements and notes should be read in conjunction with the financial statements and notes for the year ended December 31, 2012 included in the Company’s Form 8-K filed with the Securities and Exchange Commission on August 1, 2013.
	The Merger was accounted for as a “reverse merger.” Furthermore, the Merger was deemed to be a recapitalization of IH LLC, and as such, all capital accounts have been restated as if the Merger had occurred prior to the earliest period presented. IH LLC was deemed to be the acquirer in the Merger for accounting purposes. Consequently, the assets and liabilities and the historical operations of the Company that are reflected in the condensed consolidated financial statements prior to the Merger are those of IH LLC, and the condensed consolidated financial statements of the Company after completion of the Merger include the assets and liabilities of IH LLC, historical operations of IH LLC and operations of IH LLC from the Closing Date of the Merger.
	Use of Estimates
	The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. Actual results could differ from these estimates.
	Earnings per Share
	Basic earnings per share (“EPS”) is computed by dividing net income applicable to common stock by the weighted-average number of common shares outstanding less unvested restricted stock of 1,445,000 shares.
	For purposes of calculating basic and diluted earnings per share, vested restricted stock awards are considered outstanding. Under the treasury stock method, diluted EPS reflects the potential dilution that could occur if securities or other instruments that are convertible into common stock were exercised or could result in the issuance of common stock. The following financial instruments were not included in the diluted loss per share calculation for the three and nine month periods ended September 30, 2013 because their effect was anti-dilutive:
		As of September 30,
		2013
	Common stock options		200,000
	Common stock warrants		1,980,308
	Restricted stock		1,445,000
	Preferred stock		14,999,000
	Excluded potentially dilutive securities		18,624,308
	For the three and nine month periods ended September 30, 2012, diluted earnings per share includes the dilutive effects of 14,999,000 shares of preferred stock convertible into 14,999,000 shares of common stock using the if converted method.
	Revenue Recognition
	Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.
	Licensing Fees
	We derive the majority of our revenue from patent licensing. In general, these revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company’s operating subsidiaries, (ii) a covenant-not-to-litigate, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional minimum upfront payment. The Company recognizes licensing fees when there is persuasive evidence of a licensing arrangement, fees are fixed or determinable, delivery has occurred and collectability is reasonably assured.
	Patent Sales
	All patents have been internally developed. Research and development cost, if any, are expensed as incurred. The Company monetizes its intellectual property to include the sale of select patent assets. As patent sales represents a component of the Company’s ongoing major or central operations and activities, the Company records the related proceeds as revenue. The Company recognizes the patent sales revenue when there is persuasive evidence of a sales arrangement, fees are fixed or determinable, delivery has occurred and collectability is reasonably assured. These requirements are generally fulfilled upon closing of the patent sale transaction.
	Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.
	The Company assesses the collectability of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectability becomes reasonably assured, assuming all other revenue recognition criteria have been met.
	Cost of Revenues
	Cost of revenues include the costs and expenses incurred in connection with the Company’s patent licensing activities, including contingent legal fees paid to external litigation counsel, licensing related research, consulting and other expenses paid to third parties. These costs are included under the caption “Cost of Revenues” in the accompanying Condensed Consolidated Statements of Operations.
	Contingent Legal and Consulting Fees
	Contingent legal and consulting fees are expensed in the Condensed Consolidated Statements of Operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal and consulting fees are required to be paid; however, the Company may be liable for certain out of pocket legal and consulting costs incurred pursuant to the underlying legal and consulting services agreement. Legal fees advanced by contingent law firms, if any, that are required to be paid in the event that no license recoveries are obtained are expensed as incurred and included in liabilities in the Condensed Consolidated Balance Sheets.
	Investments
	In cases where the Company’s investment is less than 20% of the outstanding voting stock and significant influence does not exist, the investment is carried at cost.
	Income Taxes
	As a result of the Merger, beginning on September 18, 2013, the Company’s results of operations are taxed as a C Corporation. Prior to the Merger, the Company’s operations were taxed as a limited liability company, whereby the Company elected to be taxed as a partnership and the income or loss was required to be reported by each respective member on their separate income tax returns. Therefore, no provision for income taxes has been provided in the accompanying condensed consolidated financial statements for periods prior to September 18, 2013.
	The unaudited pro forma computation of income tax (benefit) included in the Condensed Consolidated Statements of Operations, represents the tax effects that would have been reported had the Company been subject to U.S. federal and state income taxes as a corporation for all periods presented. Pro forma taxes are based upon the statutory income tax rates and adjustments to income for estimated permanent differences occurring during each period. Actual rates and expenses could have differed had the Company actually been subject to U.S. federal and state income taxes for all periods presented. Therefore, the unaudited pro forma amounts are for informational purposes only and are intended to be indicative of the results of operations had the Company been subject to U.S. federal and state income taxes as a corporation for all periods presented.
	The Company recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statements or tax returns. Deferred tax liabilities and assets are determined based on the difference between the financial statement basis and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The Company estimates the degree to which tax assets and credit carryforwards will result in a benefit based on expected profitability by tax jurisdiction. A valuation allowance for such tax assets and loss carryforwards is provided when it is determined to be more likely than not that the benefit of such deferred tax asset will not be realized in future periods. Tax benefits of operating loss carryforwards are evaluated on an ongoing basis, including a review of historical and projected future operating results, the eligible carryforward period, and other circumstances. If it becomes more likely than not that a tax asset will be used, the related valuation allowance on such assets would be reduced.
	Revenue Concentrations
	The Company considers significant revenue concentrations to be counterparties who account for 10% or more of the total revenues generated by the Company during the period. The Company had three such counterparties who accounted for 89% of total revenues during the nine months ended September 30, 2013 and two such counterparties who accounted for 41% of total revenues during the nine months ended September 30, 2012. During the three months ended September 30, 2013, the Company only had one settlement with one counterparty and during the three months ended September 20, 2012, the Company had settlements with three counterparties who accounted for 74% of total revenues.
	Stock Based Compensation
	The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on interim financial reporting dates and vesting dates until the service period is complete. The fair value amount is then recognized over the period services are required to be provided in exchange for the award, usually the vesting period. The Company recognizes stock-based compensation expense on a graded-vesting basis over the requisite service period for each separately vesting tranche of each award. Stock-based compensation expense is reflected within operating expenses in the condensed consolidated statements of operations.
	Net Contribution (Distribution) to Related Party Shareholder
	Net contribution (distribution) to related party shareholder consists of non-cash net transfers to/from Walker Digital in relation to cash pooling and various allocations.
	Recently Issued Accounting Pronouncements
	Management does not believe that any recently issued, but not yet effective accounting pronouncements, if adopted, would have a significant effect to the accompanying condensed consolidated financial statements.

Investments

Investments	9 Months Ended
	Sep. 30, 2013
Investments	'
	NOTE 3 – INVESTMENTS
	The Company received 57,000 shares of common stock in Tagged, Inc. as part of payment in connection with a license agreement. The par value per share is $.0001. If on liquidation date (i.e. public offering or change of control), the grant value of the stock is less than $250 thousand (“grant value” or “floor value”), Tagged will pay the Company the difference between the $250 thousand floor value and the grant value. The investment is carried at cost.

SHARED_SERVICES_AGREEMENT

SHARED SERVICES AGREEMENT	9 Months Ended
	Sep. 30, 2013
SHARED SERVICES AGREEMENT	'
	NOTE 4 – SHARED SERVICES AGREEMENT
	In connection with the Merger, the Company entered into a Shared Services Agreement (“Shared Services Agreement”) with Walker Digital Management (“WDM”), which became effective at the closing of the Merger. The cost of such services varies monthly based on the terms of the Shared Services Agreement. The Company incurred a nominal amount of cost under this Shared Services Agreement from the Closing of the Merger through September 30, 2013. The incurred expenses prior to the Closing of the Merger, including but not limited to executive compensation, information technology services and supplies, administrative and general services and supplies and rent and utilities, are based either on specific attribution of those expenses or, where necessary and appropriate, based on the Company’s best estimate of an appropriate proportional allocation.
	The following table represent expenses contributed by WDM on behalf of the Company and expenses incurred under the Shares Services Agreement:
	(dollars in thousands)
		Three Months Ended		Three Months Ended		Nine Months Ended		Nine Months Ended
		September 30,		September 30,		September 30,		September 30,
		2013		2012		2013		2012
	Operating Expenses:
	Rent and Utilities	$	19	$	28	$	63	$	84
	Compensation and benefits		596		1,085		769		1,759
	Insurance		1		—		1		5
	Telephone		1		2		6		8
	Office Services and Supplies		18		7		32		19
	Other		2		8		8		14
	Total Operating Expenses:	$	637	$	1,130	$	879	$	1,889

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2013
COMMITMENTS AND CONTINGENCIES	'
	NOTE 5 – COMMITMENTS AND CONTINGENCIES
	Leases
	The Company’s corporate headquarters is located at Two High Ridge Park, Stamford, Connecticut. The Company leases space pursuant to the Shared Services Agreement. The lease will expire in September of 2015. The annual rent for the office space occupied by the Company is approximately $0.1 million.
	Effective September 18, 2013, the Company assumed a lease agreement for office space in New York, New York. The monthly cost is approximately $5,000 per month. Under this agreement, which expires on June 30, 2015, the Company may terminate the agreement at any time, with 90 days advance notice. On September 27, 2013, the Company exercised the 90 days advance notice option and accordingly the lease will terminate December 31, 2013.
	Litigation
	The Company is subject to claims, counterclaims and legal actions that arise in the ordinary course of business. Management believes that the ultimate liability with respect to these claims and legal actions, if any, will not have a material effect on the Company’s financial position, results of operations or cash flows. The Company recognizes a liability for a contingency when it is probable that liability has been incurred and when the amount of loss can be reasonably estimated. When a range of probable loss can be estimated, the Company accrues the most likely amount of such loss, at no less than the minimum of the range. As of September 30, 2013 and December 31, 2012, the litigation accrual was zero.

EQUITY

EQUITY	9 Months Ended
	Sep. 30, 2013
EQUITY	'
	NOTE 6 – EQUITY
	As of September 30, 2013, the Company had authorized and issued an aggregate of 100,000,000 shares of common stock, par value $0.001 per share. In addition, as of September 30, 2013. The Company, had authorized and issued an aggregate of 15,000,000 shares of preferred stock, par value $0.001 per share, 14,999,000 shares of which have been designated Series B Convertible Preferred Stock. As of September 30, 2013, there were 21,134,744 shares of the Company’s common stock issued and 20,741,572 outstanding. As of September 30, 2013, 14,999,000 shares of the Company’s Series B Convertible Preferred Stock were issued and outstanding.
	Description of our Common Stock
	The holders of our common stock are entitled to one vote per share. Our Certificate of Incorporation does not provide for cumulative voting. The holders of our common stock are entitled to receive ratably such dividends, if any, as may be declared by the Board of Directors out of legally available funds pari passu with the holders of our Series B Convertible Preferred Stock, on an as-converted to common stock basis.
	Upon liquidation, dissolution or winding-up of our company, the holders of our common stock and the holders of the Series B Convertible Preferred Stock, based on the number of shares of our common stock into which the Series B Convertible Preferred Stock is convertible, are entitled to share ratably in all assets of our company which are legally available for distribution, after payment of or provision for all actual and potential liabilities and the liquidation preference of any outstanding preferred stock bearing such a preference, of which currently there are none. The holders of our common stock have no preemptive, subscription, redemption or conversion rights.
	Description of Our Series B Convertible Preferred Stock
	Holders of our Series B Convertible Preferred Stock are entitled at any time to convert their shares of Series B Convertible Preferred Stock into an equal number of shares of our common stock, subject to adjustment in the event of a stock dividend, subdivision or combination of our common stock. Upon liquidation, dissolution or winding-up of our Company, the holders of our common stock and the holders of the Series B Convertible Preferred Stock, based on the number of shares of our common stock into which the Series B Convertible Preferred Stock is convertible, are entitled to share ratably in all assets of our company which are legally available for distribution, after payment of or provision for all actual and potential liabilities and the liquidation preference of any outstanding preferred stock bearing such a preference, of which currently there are none. In the event of any liquidation, dissolution or winding up of us, our assets legally available for distribution will be distributed ratably among the holders of the Series B Convertible Preferred Stock and our common stock, based on the number of shares of our common stock into which the Series B Convertible Preferred Stock is convertible. The holders of our Series B Convertible Preferred Stock are entitled to receive ratably such dividends, if any, as may be declared by the Board of Directors out of legally available funds, pari passu on an as-converted to common stock basis with the amount of such dividends to be distributed to the holders of our common stock immediately prior to the declaration of such dividend or distribution. The shares of Class B Convertible Preferred Stock will vote together with our common stock on all matters where stockholders are entitled to vote. The holders of shares of Series B Convertible Preferred Stock are entitled to cast an aggregate of 80.0% of the total votes that may be cast with respect to any such matter, including the election of all directors.
	Equity Transactions
	On September 18, 2013 (“Closing Date”), the Company issued to Walker Digital 7,667,667 shares of the Company’s common stock and 14,999,000 shares of Series B Convertible Preferred Stock resulting in Walker Digital receiving approximately 37% of the issued and outstanding shares of our common stock and all of our issued and outstanding shares of Series B Convertible Preferred Stock. Each share of Series B Convertible Preferred Stock may be converted into one share of common stock at any time and from time to time. Walker Digital may also receive an additional 2,166,667 shares subject to certain performance conditions. The Company received $15.4 million in connection with the Merger.
	On September 18, 2013, the Company completed the closing of a private placement (the “Placement”) of units, each consisting of one newly issued share of common stock and one warrant to purchase half a share of newly issued common stock, at the price of $3.00 per unit, to unaffiliated, accredited third parties. The investors in the Placement collectively purchased 3,960,615 shares of common stock and warrants to purchase 1,980,318 shares of common stock for consideration, net of offering costs of $11.7 million. The warrants (the “Warrants”) issued to the investors are exercisable for a period of three years at a purchase price of $3.00 per share of common stock and are subject to a call that permits the Company to redeem the Warrants if the closing price of the common stock of the Company equals or exceeds $6.00 per share for any 20 trading days within any period of 30 consecutive trading days.
	On July 10, 2013, the Company issued to Broadband Capital Management, LLC (“BCM”) 1,325,776 shares of restricted common stock as consideration for BCM’s services in connection with the Merger. The common stock vested on September 18, 2013. The fair value of this award amounted to $4.4 million based upon the closing stock price on the Closing date. The Company recorded the fair value of this award as a component of professional fees.
	On September 18, 2013, The Company issued to each of Dr. Schiller and Mr. Nyweide 100,000 and 83,334 shares of common stock, respectively. Such shares were fully vested and issued upon the closing of the Merger. The fair value of this award amounted to $0.6 million based upon the closing stock price on the Closing date. The Company recorded the fair value of this award as a component of compensation and benefits.
	On September 18, 2013, in connection with the amendment of a service agreement with a vendor pursuant to which the vendor reduced its future fees, the Company issued 1,445,000 shares of common stock to the vendor. The common stock will vest in six months from the Closing date. The Company recorded the pro rata portion of this non-employee award as a component of professional fees. The amounts recorded to such award were $0.3 million for both the three and nine months ended September 30, 2013.
	Registration Rights
	On September 18, 2013, upon the closing of a private placement (the “Placement”) of newly issued shares of the Company’s common stock and warrants, the Company entered into a registration rights agreement (the “Offering Registration Rights Agreement”) with the investors participating in the Placement. Under the terms of the Offering Registration Rights Agreement, the Company committed to file a registration statement covering the resale of the common stock issued in the Placement, as well as the common stock issuable on exercise of the warrants, within 30 calendar days from the Closing Date of the Placement (the “Filing Deadline”) and to use reasonable best efforts to cause the registration statement to become effective no later than the earlier of: (i) the 90th calendar day following the Closing Date, provided , that, if the Commission reviews and has written comments to the filed registration statement, then such date shall be the 180th calendar day following the Closing Date, and (ii) the 5th trading day following the date on which we are notified by the Commission that the registration statement will not be reviewed or is no longer subject to further review and comments and the effectiveness of the registration statement may be accelerated (the “Effective Deadline”).
	In the Offering Registration Rights Agreement, the Company agreed to use reasonable best efforts to maintain the effectiveness of the registration statement until the earlier of (i) such time when all of the shares of common stock covered by such registration statement have been publicly sold by the holders and (ii) the date on which all of such shares are (A) sold pursuant to an effective registration statement; (B) are sold pursuant to Rule 144 under circumstances in which any legend borne by such shares are removed; or (C) such shares would be saleable pursuant to Rule 144 without restrictions on volume or manner of sale (which shall be no earlier than one (1) year from the Closing Date) (the “Effectiveness Period”). If (i) the registration statement is not filed on or prior to its Filing Deadline, (ii) the Company fails to have the registration statement declared effective prior to the Effective Deadline, or (iii) after the Effective Deadline, such registration statement ceases to remain continuously effective for more than 30 consecutive calendar days or more than an aggregate of 60 calendar days during any 12-month period (subject to certain grace periods), the Company will be liable to each holder, as partial liquidated damages, to pay an amount, payable monthly, equal to 1.0% of the aggregate purchase price paid by such holder in the Placement for the number of shares of unregistered shares registrable under the Offering Registration Rights Agreement then held by such holder. The maximum aggregate liquidated damages payable to a holder under the Offering Registration Rights Agreement is 10.0% of the aggregate amount of such holder’s investment in the Placement, and certain other limitations apply to the accrual of liquidated damages under the Offering Registration Rights Agreement. The liquidated damages pursuant to the terms of the Offering Registration Rights Agreement apply on a daily pro rata basis for any portion of a month prior to the cure of the event resulting in the incurrence of liquidated damages. The Company’s Form S-1 Registration Statement was filed with the Securities and Exchange Commission (the “SEC”) on October 17, 2013.
	The Company accounts for our obligations under the Registration Rights Agreement in accordance with ASC 450 “Contingencies,” which requires us to record a liability if the contingent loss is probable and the amount can be estimated. At September 30, 2013, we have not recorded a liability pertaining to our obligations under the Registration Rights Agreement because the amount is not deemed probable.

STOCK_BASED_COMPENSATION

STOCK BASED COMPENSATION	9 Months Ended
	Sep. 30, 2013
STOCK BASED COMPENSATION	'
	NOTE 7 – STOCK BASED COMPENSATION
	Stock Based Compensation to Non-employees
	Stock-based compensation expense related to stock-based awards to non-employees is recognized as the stock-based awards are earned, generally through the provision of services. The Company believes that the fair value of the stock-based awards is more reliably measurable than the fair value of the services received. The fair value of the granted stock-based awards is calculated at each reporting date. On September 18, 2013, in connection with the amendment of a service agreement with a vendor pursuant to which the vendor reduced its future fees, the Company issued 1,445,000 shares of common stock to the vendor. The common stock will vest in six months from the Closing date. Stock-based compensation expense related to non-employee grants was $0.3 million for both the three and nine months ended September 30, 2013, compared to $0 for both the three and nine months ended September 30, 2012.
	Stock Based Compensation to Employees
	Amended and Restated 2006 Long-Term Incentive Plan (“Incentive Plan”)
	The Incentive Plan provided for the issuance of up to 3,000,000 shares of the Company’s common stock. The Compensation Committee had the authority to determine the amount, type and terms of each award, but may not grant awards under the Incentive Plan, in any combination, for more than 625,000 shares of the Company’s common stock to any individual during any calendar year.
	As of September 30, 2013, 1,407,342 shares of common stock remain eligible to be issued under the Incentive Plan.
	On October 8, 2013, the Company amended the Incentive Plan as follows:
		•		the number of shares authorized for issuance under the Incentive Plan increased from 3,000,000 to 6,000,000;
		•		the number of shares that may be granted to an individual during any calendar year would be increased from 625,000 to 1,000,000; and
		•		additional administrative amendments regarding certain issues arising under Section 409A of the Internal Revenue Code of 1986, as amended.
	Stock Options to Employees
	On March 16, 2012, the Company granted, in the aggregate, options for the purchase of 200,000 shares of its Common Stock at an exercise price of $3.05 per share, under the Incentive Plan, to two executives of the Company. The options have a term of five years and were vested on September 16, 2012. These options have an aggregate grant date fair value of approximately $322 utilizing the Black-Scholes option pricing model with the following assumptions used: expected life of three years; volatility of 87.9%, dividends of 0%; and a risk free interest rate of 1.13%. The expected life of the options was calculated using the simplified method, using the average of the contractual term and the vesting period.
	At September 30, 2013, the fair value of stock options granted by the Company has been fully amortized. A summary of the status of the Company’s stock option plans and the changes during the nine months ended September 30, 2013, is presented in the table below:
			Number of		Weighted		Weighted		Intrinsic
			Options		Average		Average		Value
					Exercise		Remaining
					Price		Contractual
					(per share)		Life
	Options outstanding at January 1, 2013			200,000	$	3.05		4.2 years	$	—
	Granted			—	$	—
	Exercised			—	$	—
	Forfeited			—	$	—
	Options outstanding at September 30, 2013			200,000	$	3.05		3.5 years	$	—
	Exercisable, September 30, 2013			200,000	$	3.05		3.5 years	$	—

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2013
SUBSEQUENT EVENTS	'
	NOTE 8 – SUBSEQUENT EVENTS
	On November 12, 2013, the Board of Directors authorized the Company to grant 1,375,000 stock options to executives for the purchase of its common stock, pursuant to their employment agreements. The Company has not granted these options as of the date of this report.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2013
Basis of Presentation	'
	Basis of Presentation
	The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information, the instructions to Form 10-Q and the rules and regulations of the SEC. Accordingly, since they are interim statements, the accompanying condensed consolidated financial statements do not include all of the information and notes required by GAAP for annual financial statements, but reflect all adjustments consisting of normal, recurring adjustments, that are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. In the opinion of the Company’s management, all adjustments, consisting of only normal and recurring adjustments, necessary for a fair presentation of the financial position and the results of operations for the periods presented have been included. Interim results are not necessarily indicative of results for a full year. The condensed consolidated financial statements and notes should be read in conjunction with the financial statements and notes for the year ended December 31, 2012 included in the Company’s Form 8-K filed with the Securities and Exchange Commission on August 1, 2013.
	The Merger was accounted for as a “reverse merger.” Furthermore, the Merger was deemed to be a recapitalization of IH LLC, and as such, all capital accounts have been restated as if the Merger had occurred prior to the earliest period presented. IH LLC was deemed to be the acquirer in the Merger for accounting purposes. Consequently, the assets and liabilities and the historical operations of the Company that are reflected in the condensed consolidated financial statements prior to the Merger are those of IH LLC, and the condensed consolidated financial statements of the Company after completion of the Merger include the assets and liabilities of IH LLC, historical operations of IH LLC and operations of IH LLC from the Closing Date of the Merger.
Use Of Estimates	'
	Use of Estimates
	The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. Actual results could differ from these estimates.
Earnings Per Share	'
	Earnings per Share
	Basic earnings per share (“EPS”) is computed by dividing net income applicable to common stock by the weighted-average number of common shares outstanding less unvested restricted stock of 1,445,000 shares.
	For purposes of calculating basic and diluted earnings per share, vested restricted stock awards are considered outstanding. Under the treasury stock method, diluted EPS reflects the potential dilution that could occur if securities or other instruments that are convertible into common stock were exercised or could result in the issuance of common stock. The following financial instruments were not included in the diluted loss per share calculation for the three and nine month periods ended September 30, 2013 because their effect was anti-dilutive:
		As of September 30,
		2013
	Common stock options		200,000
	Common stock warrants		1,980,308
	Restricted stock		1,445,000
	Preferred stock		14,999,000
	Excluded potentially dilutive securities		18,624,308
	For the three and nine month periods ended September 30, 2012, diluted earnings per share includes the dilutive effects of 14,999,000 shares of preferred stock convertible into 14,999,000 shares of common stock using the if converted method.
Revenue Recognition	'
	Revenue Recognition
	Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.
	Licensing Fees
	We derive the majority of our revenue from patent licensing. In general, these revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company’s operating subsidiaries, (ii) a covenant-not-to-litigate, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional minimum upfront payment. The Company recognizes licensing fees when there is persuasive evidence of a licensing arrangement, fees are fixed or determinable, delivery has occurred and collectability is reasonably assured.
	Patent Sales
	All patents have been internally developed. Research and development cost, if any, are expensed as incurred. The Company monetizes its intellectual property to include the sale of select patent assets. As patent sales represents a component of the Company’s ongoing major or central operations and activities, the Company records the related proceeds as revenue. The Company recognizes the patent sales revenue when there is persuasive evidence of a sales arrangement, fees are fixed or determinable, delivery has occurred and collectability is reasonably assured. These requirements are generally fulfilled upon closing of the patent sale transaction.
	Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.
	The Company assesses the collectability of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectability becomes reasonably assured, assuming all other revenue recognition criteria have been met.
Cost of Revenue	'
	Cost of Revenues
	Cost of revenues include the costs and expenses incurred in connection with the Company’s patent licensing activities, including contingent legal fees paid to external litigation counsel, licensing related research, consulting and other expenses paid to third parties. These costs are included under the caption “Cost of Revenues” in the accompanying Condensed Consolidated Statements of Operations.
Contingent Legal and Consulting Fees	'
	Contingent Legal and Consulting Fees
	Contingent legal and consulting fees are expensed in the Condensed Consolidated Statements of Operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal and consulting fees are required to be paid; however, the Company may be liable for certain out of pocket legal and consulting costs incurred pursuant to the underlying legal and consulting services agreement. Legal fees advanced by contingent law firms, if any, that are required to be paid in the event that no license recoveries are obtained are expensed as incurred and included in liabilities in the Condensed Consolidated Balance Sheets.
Investments	'
	Investments
	In cases where the Company’s investment is less than 20% of the outstanding voting stock and significant influence does not exist, the investment is carried at cost.
Income Taxes	'
	Income Taxes
	As a result of the Merger, beginning on September 18, 2013, the Company’s results of operations are taxed as a C Corporation. Prior to the Merger, the Company’s operations were taxed as a limited liability company, whereby the Company elected to be taxed as a partnership and the income or loss was required to be reported by each respective member on their separate income tax returns. Therefore, no provision for income taxes has been provided in the accompanying condensed consolidated financial statements for periods prior to September 18, 2013.
	The unaudited pro forma computation of income tax (benefit) included in the Condensed Consolidated Statements of Operations, represents the tax effects that would have been reported had the Company been subject to U.S. federal and state income taxes as a corporation for all periods presented. Pro forma taxes are based upon the statutory income tax rates and adjustments to income for estimated permanent differences occurring during each period. Actual rates and expenses could have differed had the Company actually been subject to U.S. federal and state income taxes for all periods presented. Therefore, the unaudited pro forma amounts are for informational purposes only and are intended to be indicative of the results of operations had the Company been subject to U.S. federal and state income taxes as a corporation for all periods presented.
	The Company recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statements or tax returns. Deferred tax liabilities and assets are determined based on the difference between the financial statement basis and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The Company estimates the degree to which tax assets and credit carryforwards will result in a benefit based on expected profitability by tax jurisdiction. A valuation allowance for such tax assets and loss carryforwards is provided when it is determined to be more likely than not that the benefit of such deferred tax asset will not be realized in future periods. Tax benefits of operating loss carryforwards are evaluated on an ongoing basis, including a review of historical and projected future operating results, the eligible carryforward period, and other circumstances. If it becomes more likely than not that a tax asset will be used, the related valuation allowance on such assets would be reduced.
Revenue Concentrations	'
	Revenue Concentrations
	The Company considers significant revenue concentrations to be counterparties who account for 10% or more of the total revenues generated by the Company during the period. The Company had three such counterparties who accounted for 89% of total revenues during the nine months ended September 30, 2013 and two such counterparties who accounted for 41% of total revenues during the nine months ended September 30, 2012. During the three months ended September 30, 2013, the Company only had one settlement with one counterparty and during the three months ended September 20, 2012, the Company had settlements with three counterparties who accounted for 74% of total revenues.
Stock Based Compensation	'
	Stock Based Compensation
	The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on interim financial reporting dates and vesting dates until the service period is complete. The fair value amount is then recognized over the period services are required to be provided in exchange for the award, usually the vesting period. The Company recognizes stock-based compensation expense on a graded-vesting basis over the requisite service period for each separately vesting tranche of each award. Stock-based compensation expense is reflected within operating expenses in the condensed consolidated statements of operations.
Net Contribution (Distribution) to Related Party Shareholder	'
	Net Contribution (Distribution) to Related Party Shareholder
	Net contribution (distribution) to related party shareholder consists of non-cash net transfers to/from Walker Digital in relation to cash pooling and various allocations.
Recently Issues Accounting Pronouncement	'
	Recently Issued Accounting Pronouncements
	Management does not believe that any recently issued, but not yet effective accounting pronouncements, if adopted, would have a significant effect to the accompanying condensed consolidated financial statements.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2013
Financial Instruments that Were Not Included in Diluted Loss Per Share Calculation	'
	The following financial instruments were not included in the diluted loss per share calculation for the three and nine month periods ended September 30, 2013 because their effect was anti-dilutive:
		As of September 30,
		2013
	Common stock options		200,000
	Common stock warrants		1,980,308
	Restricted stock		1,445,000
	Preferred stock		14,999,000
	Excluded potentially dilutive securities		18,624,308

SHARED_SERVICES_AGREEMENT_Tabl

SHARED SERVICES AGREEMENT (Tables)	9 Months Ended
	Sep. 30, 2013
Summery Of Expenses Contributed by WDM on Behalf of the Company and Expenses Incurred under the Shares Services Agreement:	'
	The following table represent expenses contributed by WDM on behalf of the Company and expenses incurred under the Shares Services Agreement:
	(dollars in thousands)
		Three Months Ended		Three Months Ended		Nine Months Ended		Nine Months Ended
		September 30,		September 30,		September 30,		September 30,
		2013		2012		2013		2012
	Operating Expenses:
	Rent and Utilities	$	19	$	28	$	63	$	84
	Compensation and benefits		596		1,085		769		1,759
	Insurance		1		—		1		5
	Telephone		1		2		6		8
	Office Services and Supplies		18		7		32		19
	Other		2		8		8		14
	Total Operating Expenses:	$	637	$	1,130	$	879	$	1,889

STOCK_BASED_COMPENSATION_Table

STOCK BASED COMPENSATION (Tables)	9 Months Ended
	Sep. 30, 2013
Summary of Stock Option Plans and Changes	'
	A summary of the status of the Company’s stock option plans and the changes during the nine months ended September 30, 2013, is presented in the table below:
		Number of		Weighted		Weighted		Intrinsic
		Options		Average		Average		Value
				Exercise		Remaining
				Price		Contractual
				(per share)		Life
	Options outstanding at January 1, 2013		200,000	$	3.05		4.2 years	$	—
	Granted		—	$	—
	Exercised		—	$	—
	Forfeited		—	$	—
	Options outstanding at September 30, 2013		200,000	$	3.05		3.5 years	$	—
	Exercisable, September 30, 2013		200,000	$	3.05		3.5 years	$	—

Recovered_Sheet1

Organization And Nature Of Business - Additional Information (Detail) (USD $)	1 Months Ended	9 Months Ended
	Sep. 18, 2013	Sep. 30, 2013	Dec. 31, 2012
Organization Consolidation And Presentation Of Financial Statements [Line Items]	'	'	'
Preferred stock, par value	'	$0.00	$0.00
Common stock, shares issued	7,667,667	21,134,744	7,667,667
Common stock, par value	$0.00	$0.00	$0.00
Issued and outstanding common stock percentage	64.00%	'	'
Controlling voting interest owned as a result of merger	87.40%	'	'
Lock up period for share acquisition	'1 year	'	'
Warrants issued to purchase common stock	'	1,980,318	'
Stock issued during period value new issues	'	$11,694,000	'
Offering costs	'	200,000	'
Performance Shares	'	'	'
Organization Consolidation And Presentation Of Financial Statements [Line Items]	'	'	'
Shares of common stock to be received	2,166,667	'	'
Series B Convertible Preferred Stock [Member]	'	'	'
Organization Consolidation And Presentation Of Financial Statements [Line Items]	'	'	'
Preferred stock, shares issued	14,999,000	'	'
Preferred stock, par value	$0.00	'	'
Percentage of stock acquired by walker digital	100.00%	'	'
Common Stock	'	'	'
Organization Consolidation And Presentation Of Financial Statements [Line Items]	'	'	'
Percentage of stock acquired by walker digital	37.00%	'	'
Private Placement, Global Options	'	'	'
Organization Consolidation And Presentation Of Financial Statements [Line Items]	'	'	'
Offering price of share issued	'	$3	'
Stock issued during period shares new issues	'	3,960,615	'
Warrants issued to purchase common stock	'	1,980,318	'
Stock issued during period value new issues	'	11,700,000	'
Offering costs	'	$200,000	'
Warrant exercisable period	'	'3 years	'
Warrant exercise price	'	3	'
Closing price per share	'	$6	'
Number of trading days	'	'20 days	'
Number of consecutive trading days	'	'30 days	'

Recovered_Sheet2

Summary Of Significant Accounting Policies - Additional Information (Detail)	3 Months Ended	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Significant Accounting Policies [Line Items]	'	'	'
Anti dilutive securities	'	18,624,308	'
Dilutive effects of convertible preferred stock	14,999,000	'	14,999,000
Restricted Stock [Member]	'	'	'
Significant Accounting Policies [Line Items]	'	'	'
Anti dilutive securities	'	1,445,000	1,445,000
Percentage of major customers revenue accounted for 10% or more of total revenues	'	'	'
Significant Accounting Policies [Line Items]	'	'	'
Number of major customers accounted for 10% or more of total revenues	'	3	2
Concentration percentage	'	89.00%	41.00%
Percentage of major customers revenue accounted for 10% or more of total revenues | Settled amount	'	'	'
Significant Accounting Policies [Line Items]	'	'	'
Concentration percentage	'	'	74.00%
Number of counter parties	'	1	3

Financial_Instruments_that_Wer

Financial Instruments that Were Not Included in Diluted Loss Per Share Calculation (Detail)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Excluded potentially dilutive securities	18,624,308	'
Employee Stock Option [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Excluded potentially dilutive securities	200,000	'
Warrant [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Excluded potentially dilutive securities	1,980,308	'
Restricted Stock [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Excluded potentially dilutive securities	1,445,000	1,445,000
Convertible Preferred Stock [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Excluded potentially dilutive securities	14,999,000	'

Investments_Additional_Informa

Investments - Additional Information (Detail) (USD $)	Sep. 30, 2013	Sep. 18, 2013	Dec. 31, 2012	Sep. 30, 2013
In Thousands, except Share data, unless otherwise specified				Licensing Agreements
Schedule of Cost-method Investments [Line Items]	'	'	'	'
Number of Common stock received in connection with license agreement	'	'	'	57,000
Par value	$0.00	$0.00	$0.00	$0.00
Investments, at cost	$250	'	$250	$250

General_And_Administrative_Exp

General And Administrative Expenses (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Operating expenses:	'	'	'	'
Compensation and benefits	$1,456	$1,296	$2,052	$2,659
Total operating expenses	7,320	1,502	8,685	3,409
Shared Services Agreement	'	'	'	'
Operating expenses:	'	'	'	'
Rent and Utilities	19	28	63	84
Compensation and benefits	596	1,085	769	1,759
Insurance	1	'	1	5
Telephone	1	2	6	8
Office Services and Supplies	18	7	32	19
Other	2	8	8	14
Total operating expenses	$637	$1,130	$879	$1,889

Commitment_And_Contingencies_A

Commitment And Contingencies - Additional Information (Detail) (USD $)	1 Months Ended
	Sep. 18, 2013	Sep. 30, 2013	Dec. 31, 2012
Loss Contingencies [Line Items]	'	'	'
Annual Rent expense	'	$100,000	'
Monthly lease	5,000	'	'
Lease Expiry Date	30-Jun-15	'	'
Lease termination, advance notice period	'90 days	'	'
Litigation accrual	'	$0	$0

Equity_Additional_Information_

Equity - Additional Information (Detail) (USD $)	1 Months Ended			3 Months Ended	9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2013	Sep. 18, 2013	Jul. 10, 2013	Sep. 30, 2013	Sep. 30, 2013	Dec. 31, 2012
Equity [Line Items]	'	'	'	'	'	'
Common stock, authorized	100,000,000	'	'	100,000,000	100,000,000	100,000,000
Common stock, par value	$0.00	$0.00	'	$0.00	$0.00	$0.00
Common Stock, Issued	21,134,744	7,667,667	'	21,134,744	21,134,744	7,667,667
Preferred stock, authorized	15,000,000	'	'	15,000,000	15,000,000	15,000,000
Preferred stock, par value	$0.00	'	'	$0.00	$0.00	$0.00
Common stock, shares outstanding	20,741,572	'	'	20,741,572	20,741,572	'
Votiing right by holders of common stock	'	'	'	'	'One vote per share	'
Preferred stock voting percentage	'	'	'	'	80.00%	'
Cash received from the merger	'	$15,394	'	'	($15,394)	'
Warrants issued to purchase common stock	1,980,318	'	'	1,980,318	1,980,318	'
Stock issued during period value new issues	'	'	'	'	11,694	'
Incentive shares vested - financial adviser, shares	'	'	1,325,776	'	'	'
Incentive shares vested - financial adviser, value	'	'	4,441	'	'	'
Incentive shares granted- Vendor, Shares	1,445,000	'	'	'	1,445,000	'
Incentive shares granted- Vendor, Value	'	'	'	343	343	'
Performance Shares	'	'	'	'	'	'
Equity [Line Items]	'	'	'	'	'	'
Shares of common stock to be received	'	2,166,667	'	'	'	'
Employee Stock	'	'	'	'	'	'
Equity [Line Items]	'	'	'	'	'	'
Incentive shares vested - financial adviser, value	'	'	'	'	614	'
Incentive shares vested, value	'	614	'	'	'	'
Employee Stock | Dr Schiller [Member]	'	'	'	'	'	'
Equity [Line Items]	'	'	'	'	'	'
Incentive shares vested - financial adviser, shares	'	100,000	'	'	'	'
Employee Stock | Mr Nyweid [Member]	'	'	'	'	'	'
Equity [Line Items]	'	'	'	'	'	'
Incentive shares vested - financial adviser, shares	'	83,334	'	'	'	'
Private Placement, Global Options	'	'	'	'	'	'
Equity [Line Items]	'	'	'	'	'	'
Offering price of share issued	$3	'	'	$3	$3	'
Stock issued during period shares new issues	'	'	'	'	3,960,615	'
Warrants issued to purchase common stock	1,980,318	'	'	1,980,318	1,980,318	'
Stock issued during period value new issues	'	'	'	'	$11,700	'
Warrant exercisable period	'	'	'	'	'3 years	'
Warrant exercise price	3	'	'	3	3	'
Closing price per share	$6	'	'	$6	$6	'
Number of trading days	'	'	'	'	'20 days	'
Number of consecutive trading days	'	'	'	'	'30 days	'
Series B Convertible Preferred Stock	'	'	'	'	'	'
Equity [Line Items]	'	'	'	'	'	'
Preferred Stock, Issued	14,999,000	'	'	14,999,000	14,999,000	14,999,000
Preferred stock, shares outstanding	14,999,000	'	'	14,999,000	14,999,000	14,999,000
Series B Convertible Preferred Stock [Member]	'	'	'	'	'	'
Equity [Line Items]	'	'	'	'	'	'
Preferred stock, par value	'	$0.00	'	'	'	'
Preferred Stock, Issued	'	14,999,000	'	'	'	'
Prefered stock conversion bases	'	'Each share of Series B Convertible Preferred Stock may be converted into one share of common stock at any time and from time to time.	'	'	'	'
Percentage of stock acquired by walker digital	'	100.00%	'	'	'	'
Common Stock	'	'	'	'	'	'
Equity [Line Items]	'	'	'	'	'	'
Percentage of stock acquired by walker digital	'	37.00%	'	'	'	'

Stock_Based_Options_Additional

Stock Based Options - Additional Information (Detail) (USD $)	1 Months Ended		9 Months Ended	1 Months Ended	3 Months Ended		9 Months Ended	1 Months Ended	9 Months Ended
	Sep. 30, 2013	Mar. 16, 2012	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Oct. 08, 2013	Sep. 30, 2013
				Financial Advisory [Member]	Financial Advisory [Member]	Financial Advisory [Member]	Financial Advisory [Member]	Two Thousand Six Equity Incentive Plan [Member]	Two Thousand Six Equity Incentive Plan [Member]
Stock Based Compensation [Line Items]	'	'	'	'	'	'	'	'	'
Incentive shares granted- Vendor, Shares	1,445,000	'	1,445,000	'	'	'	'	'	'
Expected Term	'	'5 years	'	'6 months	'	'	'	'	'
Stock based compensation expense	'	'	$5,398,000	$300,000	$300,000	$0	$0	'	'
Common stock shares issued	'	'	'	'	'	'	'	6,000,000	3,000,000
Compensation award granted	'	'	'	'	'	'	'	1,000,000	625,000
Common stock remain eligible to be issued	'	'	'	'	'	'	'	'	1,407,342
Option to purchase common stock, shares granted	'	200,000	'	'	'	'	'	'	'
Option to purchase common stock, exercise price	'	$3.05	'	'	'	'	'	'	'
Option to purchase common stock, vesting date	'	16-Sep-12	'	'	'	'	'	'	'
Options vested, aggregate grant date fair value	'	$322	'	'	'	'	'	'	'
Expected Term	'	'3 years	'	'	'	'	'	'	'
Volatility rate	'	87.90%	'	'	'	'	'	'	'
Dividends rate	'	0.00%	'	'	'	'	'	'	'
Risk free interest rat	'	113.00%	'	'	'	'	'	'	'

Summary_of_Stock_Option_Plans_

Summary of Stock Option Plans and Changes (Detail) (USD $)	1 Months Ended	9 Months Ended	12 Months Ended
	Mar. 16, 2012	Sep. 30, 2013	Dec. 31, 2012
Intrinsic Value	'	'	'
Options outstanding at end of period	'	'	'
Options outstanding at end of period	'	'	'
Weighted Average Remaining Contractual Life	'	'	'
Options outstanding at end of period	'	'3 years 6 months	'4 years 2 months 12 days
Options outstanding at end of period	'	'3 years 6 months	'
Weighted Average Exercise Price (per share)	'	'	'
Options outstanding at beginning of period	'	$3.05	'
Granted	$3.05	'	'
Exercised	'	'	'
Forfeited	'	'	'
Options outstanding end of period	'	$3.05	$3.05
Exercisable, Weighted average exercise price	'	$3.05	'
Number of options	'	'	'
Balances at beginning of period, Number of shares	'	200,000	'
Granted, Number of shares	200,000	'	'
Exercised, Number of shares	'	'	'
Forfeited, Number of shares	'	'	'
Balances at End of period, Number of shares	'	200,000	200,000
Exercisable, September 30, 2013	'	200,000	'

Subsequent_Event_Additional_In

Subsequent Event - Additional Information (Detail)	1 Months Ended	9 Months Ended	1 Months Ended
	Mar. 16, 2012	Sep. 30, 2013	Nov. 12, 2013
			Employee Stock Option [Member]
Subsequent Event [Line Items]	'	'	'
Stock options granted	200,000	'	0
Stock options granted, Authorized	'	'	1,375,000